Dextofisopam

DB06582InvestigationalSmall molecule

Investigated for use/treatment in irritable bowel syndrome (IBS).

Chemical structure of Dextofisopam
Primary indication
Investigated for use/treatment in irritable bowel syndrome (IBS).Curator reviewed
Formula / weight
C22H26N2O4 · 382.46 g/mol (avg)

Resolves to

Compound
UNIIEZ15I5D6C1CAS82059-50-5ChEMBLCHEMBL2107331
Structure
InChIKeyRUJBDQSFYCKFAA-HNNXBMFYSA-NSMILESCC[C@@H]1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC=C(OC)C(OC)=C1
Targets
P30536TSPO

What you can answer from here — as of January 29, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
680Drug interactionsStructured to mechanism, not free text
Sign in
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Dextofisopam, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In